DNAe Secures £25M Bank Facility for Point-of-Care Sepsis Dx | GenomeWeb

NEW YORK (GenomeWeb) – Infectious disease diagnostics firm DNAe today announced a bank facility of £25 million ($38.7 million) from Citibank, to fund the development of its point-of-care diagnostics for septic infections. The firm said it expects to conduct clinical trials in 2016 and launch its product in 2017. The funds will help DNAe finish its attempt to integrate its Genalysis DNA sequencing technology with its subsidiary DNA Electronics' Pathogen Capture System to create a blood test for serious infections that provides results in two to three hours, the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.